LymphoSign : IVD kit to classify Non-Hodgkin’s Lymphomas

The in-depth understanding of non-Hodgkin lymphoma (NHL) has become a major challenge, and many advances have been made since the introduction of the WHO classification in 2001.

However, the risk of diagnostic errors remains high due to the great diversity of lymphomas. There are in fact more than 80 subtypes of non-Hodgkin lymphoma, some of which are rare and particularly complex to characterize.

The LymphoSign test However, the risk of diagnostic errors remains high due to the great diversity of lymphomas. There are in fact more than 80 subtypes of non-Hodgkin lymphoma, some of which are rare and particularly complex to characterize.

This test is marked CE-IVD for diagnostic use in Vitro test, guaranteeing its compliance with European safety and performance requirements.

This test is suitable for classifying the following subgroups: